MedTrace Logo

Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users

NCT06338670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-01-21

No results posted yet for this study

Summary

This study aims to investigate the clinical performance of the Osia 3 Sound Processor in comparison to the Osia 2 Sound Processor in adults with mixed or conductive hearing loss or single-sided deafness implanted with an Osia implant. Participants will attend four study visits, where they will complete various hearing assessments using the Osia sound processors.

Conditions

  • Hearing Loss, Mixed Conductive-Sensorineural
  • Hearing Loss, Conductive

Interventions

DEVICE

Cochlear Osia 3 Sound Processor

Osia 3 Sound Processor including sound processor magnets and Osia 3 Aqua +

DEVICE

Cochlear™ Osia® 2 Sound Processor

Osia® 2 Sound Processor and Osia 2 Aqua +

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • Therese Agat · Cochlear

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-04
Primary Completion
2025-07-23
Completion
2025-07-23

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06338670 on ClinicalTrials.gov